TITLE

Wholesalers Get Lift From Generic Rxs

PUB. DATE
February 2011
SOURCE
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p80
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents a commentary by Turner Investments which reveals that higher sales of generic drugs help AmerisourceBergen Drug Corp., Cardinal Health Inc. and McKesson Corp to command over 90% market share in the 300 billion U.S. dollar drug distribution industry in the U.S.
ACCESSION #
59994659

 

Related Articles

  • Walgreens Inks New Supply Deal. Hamstra, Mark // Supermarket News Expert Blog;3/19/2013, p7 

    The article reports that Walgreen Co. has entered into a 10-year supply agreement with drug wholesaler AmerisourceBergen for branded and generic pharmaceutical products, plus an equity stake in the company.

  • Drug shortages a challenge for all.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p40 

    The article presents the remarks of AmerisourceBergen Drug Corp. senior vice president of supply chain management Tony Pera, on challenges due to the shortage of generic injectables in the drug distribution industry.

  • Program designed to be customer-friendly solution.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p42 

    The article presents the remarks of AmerisourceBergen Drug Corp. vice president of generics commercialization Chris Casey, on the firm's PRxO Generics program.

  • PRxO Generics emerges as 'critical value driver'.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p42 

    The article reports on AmerisourceBergen Drug Corp. senior vice president of global generics Marc Kikuchi, whose responsibilities include a brand-to-generic conversion program for the first 45 days that an A-rated brand goes off patent. Kikuchi spent more than 125 days in India in the last five...

  • Every minute counts at AmerisourceBergen.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p40 

    The article presents the remarks of AmerisourceBergen Drug Corp. senior vice president of supply chain management Tony Pera, on the generic drugs business of the firm. He said the generics business has multiple sources, and the company is well aware of its role in the marketplace and its actions...

  • Authorized generics yielding controversy, profits for drug makers. Kirsche, Michelle L. // Drug Store News;2/14/2005, Vol. 27 Issue 2, p22 

    Reports on the future of authorized generics in the U.S. Penetration of generic products in the market; Focus of the generic drug maker; Presence of authorized generics in the market.

  • Market Overview.  // Latin America Monitor: Brazil Monitor;Jan2005, Vol. 22 Issue 1, p6 

    Presents an overview of the pharmaceutical industry in Brazil as of January 2005. Contraction of the drug market; Share of pharmaceutical spending on the gross domestic product; Growth rate of the generic drugs sector; Market share of prescription drugs; Number of pharmaceutical companies and...

  • Generics flood market as drug patents expire. Frederick, James // Drug Store News;9/22/2003, Vol. 25 Issue 12, p24 

    Reports on the increasing market share of generic drug industry in the U.S. Result of patent expirations; Occurrence of pricing disputes; Escalation of pressure from patients and politicians.

  • Getting a handle on the specialty Rx sector. Woldt, Jeffrey // Chain Drug Review;3/17/2014, Vol. 36 Issue 5, p18 

    The article reports that research-based drug manufacturers are finding it difficult to create breakthrough products using traditional small-molecule technology, after generics suppliers continued to increase their dominant market share in terms of prescriptions dispensed in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics